Identification and Functional Characterization of a Novel Fc Gamma-Binding Glycoprotein in Rhesus Cytomegalovirus.


Journal

Journal of virology
ISSN: 1098-5514
Titre abrégé: J Virol
Pays: United States
ID NLM: 0113724

Informations de publication

Date de publication:
15 02 2019
Historique:
received: 21 11 2018
accepted: 26 11 2018
pubmed: 30 11 2018
medline: 18 12 2019
entrez: 30 11 2018
Statut: epublish

Résumé

Receptors recognizing the Fc part of immunoglobulin G (FcγRs) are key determinants in antibody-mediated immune responses. Members of the

Identifiants

pubmed: 30487278
pii: JVI.02077-18
doi: 10.1128/JVI.02077-18
pmc: PMC6364020
pii:
doi:

Substances chimiques

Antibodies, Viral 0
Carrier Proteins 0
Glycoproteins 0
Immunoglobulin G 0
Receptors, IgG 0
Viral Proteins 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIAID NIH HHS
ID : P01 AI129859
Pays : United States
Organisme : NIH HHS
ID : P51 OD011092
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI059457
Pays : United States
Organisme : NIAID NIH HHS
ID : U19 AI128741
Pays : United States

Informations de copyright

Copyright © 2019 American Society for Microbiology.

Références

Mol Immunol. 2009 Nov;47(1):114-22
pubmed: 19297023
Nature. 2011 May 26;473(7348):523-7
pubmed: 21562493
JCI Insight. 2017 Jul 6;2(13):
pubmed: 28679960
PLoS Pathog. 2016 Nov 9;12(11):e1006014
pubmed: 27829026
J Immunol Methods. 2013 Jan 31;387(1-2):21-35
pubmed: 23023090
J Virol. 1994 Dec;68(12):7757-65
pubmed: 7966565
Antimicrob Agents Chemother. 2017 Jan 24;61(2):
pubmed: 27872061
Virus Genes. 2007 Dec;35(3):577-83
pubmed: 17823862
Science. 2010 Apr 2;328(5974):102-6
pubmed: 20360110
mBio. 2018 Apr 24;9(2):
pubmed: 29691342
Adv Immunol. 2007;96:179-204
pubmed: 17981207
Proc Natl Acad Sci U S A. 2003 Nov 11;100(23):13585-90
pubmed: 14593199
Trends Immunol. 2005 Jul;26(7):396-401
pubmed: 15922665
Methods Mol Biol. 2010;634:421-30
pubmed: 20677001
Med Microbiol Immunol. 2008 Jun;197(2):109-15
pubmed: 18193454
J Virol. 2002 Sep;76(17):8596-608
pubmed: 12163579
Science. 2013 May 24;340(6135):1237874
pubmed: 23704576
Nat Med. 2009 Mar;15(3):293-9
pubmed: 19219024
J Infect Dis. 2010 Feb 1;201(3):386-9
pubmed: 20039807
J Virol Methods. 2002 Jul;104(2):135-46
pubmed: 12088823
J Virol. 2017 Mar 13;91(7):
pubmed: 28077656
J Virol. 1987 Jul;61(7):2208-16
pubmed: 3035221
J Clin Invest. 2010 Sep;120(9):3191-208
pubmed: 20679731
J Virol. 2018 Apr 13;92(9):
pubmed: 29467314
Curr Top Microbiol Immunol. 2008;325:333-59
pubmed: 18637515
J Exp Med. 2006 Aug 7;203(8):1843-50
pubmed: 16831899
J Immunol. 2006 Dec 15;177(12):8422-31
pubmed: 17142739
Nat Med. 2014 Feb;20(2):143-51
pubmed: 24412922
Cell Mol Immunol. 2015 Mar;12(2):139-53
pubmed: 25418469
Med Microbiol Immunol. 2016 Oct;205(5):409-24
pubmed: 27193020
J Gen Virol. 2016 Jun;97(6):1426-1438
pubmed: 26974598
PLoS Pathog. 2011 Dec;7(12):e1002432
pubmed: 22174689
PLoS Pathog. 2014 May 15;10(5):e1004131
pubmed: 24830376
PLoS Pathog. 2014 Mar 06;10(3):e1003961
pubmed: 24604090
Expert Opin Biol Ther. 2016;16(2):265-71
pubmed: 26865048
J Virol. 1998 Feb;72(2):1377-82
pubmed: 9445038
J Immunol. 2006 Sep 15;177(6):3848-56
pubmed: 16951347
Science. 2016 Feb 12;351(6274):714-20
pubmed: 26797147
Gene. 1995 May 26;158(1):9-14
pubmed: 7789817
J Virol. 2008 Mar;82(5):2170-81
pubmed: 18094178
J Virol. 2012 Sep;86(17):8959-73
pubmed: 22718821
Curr Opin HIV AIDS. 2013 Sep;8(5):393-401
pubmed: 23924999
Proc Natl Acad Sci U S A. 2015 Nov 3;112(44):13645-50
pubmed: 26483473
Science. 2012 Nov 23;338(6110):1088-93
pubmed: 23180859
PLoS One. 2012;7(11):e50166
pubmed: 23226246
Cochrane Database Syst Rev. 2007 Apr 18;(2):CD005129
pubmed: 17443573
J Virol. 2014 Dec;88(24):14326-39
pubmed: 25275132
mBio. 2014 Oct 28;5(6):e02035
pubmed: 25352622
J Virol. 2003 Jun;77(12):6620-36
pubmed: 12767982
J Virol. 2011 May;85(10):5105-14
pubmed: 21389128
PLoS Pathog. 2016 Aug 31;12(8):e1005868
pubmed: 27580123
J Clin Virol. 2008 Mar;41(3):206-12
pubmed: 18069056
J Gen Virol. 2003 Mar;84(Pt 3):657-663
pubmed: 12604818
Immunol Cell Biol. 2016 Oct;94(9):849-860
pubmed: 27192938
J Virol. 1998 Jul;72(7):5351-9
pubmed: 9620988
J Immunol. 2016 Oct 1;197(7):2936-47
pubmed: 27559046
N Engl J Med. 2014 Apr 3;370(14):1316-26
pubmed: 24693891
Methods Mol Biol. 2004;256:107-21
pubmed: 15024163
N Engl J Med. 2005 Sep 29;353(13):1350-62
pubmed: 16192480
J Clin Oncol. 2009 Feb 10;27(5):770-81
pubmed: 19114702
Cell. 2017 Aug 10;170(4):637-648.e10
pubmed: 28757252
Cell. 2015 Nov 5;163(4):988-98
pubmed: 26544943
J Virol. 1998 Feb;72(2):1542-51
pubmed: 9445058
Immunol Cell Biol. 2011 Oct;89(7):753-66
pubmed: 21670740
Blood. 2009 Apr 16;113(16):3716-25
pubmed: 19018092
Biol Blood Marrow Transplant. 2001;7(6):343-51
pubmed: 11464977

Auteurs

Philipp Kolb (P)

Institute of Virology, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Steven Sijmons (S)

Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, USA.

Matthew R McArdle (MR)

Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, USA.

Husam Taher (H)

Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, USA.

Jennie Womack (J)

Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, USA.

Colette Hughes (C)

Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, USA.

Abigail Ventura (A)

Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, USA.

Michael A Jarvis (MA)

Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, USA.

Christiane Stahl-Hennig (C)

German Primate Center Göttingen, Göttingen, Germany.

Scott Hansen (S)

Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, USA.

Louis J Picker (LJ)

Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, USA.

Daniel Malouli (D)

Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, USA.

Hartmut Hengel (H)

Institute of Virology, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Klaus Früh (K)

Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, USA fruehk@ohsu.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH